Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Global Health's FCF Margin % or its related term are showing as below:
BOM:543654'
s FCF Margin % Range Over the Past 10 Years
Min: -6.12 Med: 1.7 Max: 15.23
Current: -5.64
During the past 7 years, the highest FCF Margin % of Global Health was 15.23%. The lowest was -6.12%. And the median was 1.70%.
BOM:543654's FCF Margin % is ranked worse than 72.09% of 670
companies
in the Healthcare Providers & Services industry
Industry Median: 3.245
vs BOM:543654: -5.64
The historical data trend for Global Health's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543654 vs HCA, THC, DVA: FCF Margin % Comparison
For the Medical Care Facilities subindustry, Global Health's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Health FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Global Health's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Global Health's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Health (BOM:543654) has a FCF Margin % of 0.00% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Global Health and its competitors. According to the industry distribution chart, Global Health ranks #483 out of 670 companies in the Healthcare Providers & Services industry, placing it in the top 72.1%.
Is Global Health's FCF Margin % too high?
Global Health's current FCF Margin % is 0.00%. Based on the distribution chart, Global Health ranks #483 out of 670 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Global Health has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Global Health's FCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Global Health ranks #483 out of 670 companies for FCF Margin %. This places Global Health in the lower half of its industry. The industry median FCF Margin % is 3.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.25, based on 670 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Global Health and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Global Health's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Health stock overvalued right now?
Based on GuruFocus' analysis, Global Health (BOM:543654) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,562.98, compared to a current price of ₹1,404.70 — trading 10.1% below its estimated fair value. The current FCF Margin % is 0.00%. Global Health's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Global Health (BOM:543654), the current FCF Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Global Health (BOM:543654) Overvalued in 2026?
Based on GuruFocus' analysis, Global Health stock appears to be undervalued.
The current stock price of ₹1,404.70 is trading 10.1% below its estimated GF Value™ of ₹1,562.98.
GuruFocus considers Global Health to be Modestly Undervalued.
Key valuation signals for BOM:543654:
FCF Margin %: 0.00%
GF Value™: ₹1,562.98 vs. price of ₹1,404.70 (10.1% below fair value)
No single metric tells the full story. See the BOM:543654 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.
96GF Score
Get the complete analysis for BOM:543654
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543654 has been successfully added to your 
